Skip to main content

Advertisement

Log in

Serum bone GLA-protein is not a sensitive marker of bone turnover in Paget's disease of bone

  • Rapid Communications
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Summary

Serum bone Gla-protein (sBGP) was measured in 32 patients with untreated Paget's disease of bone. Despite clinical and biological symptoms of active disease in all patients, sBGP was normal in 13/32 patients (41%). There was a striking discrepancy between the moderate increase of sBGP above normal values (11.4±4.5 vs 6.0±2.1 ng/ml) and the marked increase of both serum alkaline phosphatase (sAP) and urinary hydroxyproline (uOHP). sBGP was weakly correlated with sAP (r=0.50, p<0.01), uOHP (r=0.48, p<0.01) and with the extension of the disease (r=0.48, p<0.01), We conclude that sBGP is not a sensitive marker of bone turnover in patients with Paget's disease of bone, and should be interpreted with caution in this condition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. PRICE P. A., PARTHEMORE J.G., DEFTOS L. J. (1980). New Biochemical Marker for Bone Metabolism. J. Clin. Invest. 66: 878–83

    Article  PubMed  CAS  Google Scholar 

  2. DEFTOS L. J., PARTHEMORE J. G., PRICE P. A., (1982). Changes in Plasma Bon Gla Protein during Treatment of Bone Disease. Calcif Tissue Int. 34: 121–124

    Article  PubMed  CAS  Google Scholar 

  3. GUNDBERG C. M., LIAN J. M., GALLOP P. M., STEINBERG J. J. (1983). Urinary γ Carboxyglutamic Acid and Serum Osteocalcin as Bone Markers: Studies in Osteoporosis and Paget's disease. J. Clin Endocrinol Metab. 57: 1221–1225

    Article  PubMed  CAS  Google Scholar 

  4. DELMAS P. D., WAHNER H. W., MANN K. G., RIGGS B. L. (1983). Assessment of bone turnover in postmenopausal osteoporosis by measurement of serum bone Gla-protein. J. Lab. Clin. Med. 102: 470–476

    PubMed  CAS  Google Scholar 

  5. MEUNIER P. J., COINDRE J. M., EDOUARD C. M., ARLOT M. E. (1980). Bone histomorphometry in Paget's disease. Quantitative and dynamic analysis of pagetic and nonpagetic bone tissue. Arthr. and Rheum. 23: 1095–1103

    CAS  Google Scholar 

  6. DELMAS P. D., STENNER D., WAHNER H. W., MANN K. G., RIGGS B. L. (1983) Increase in serum bone carboxyglutamic acid protein with aging in women. Implications for the mechanism of age-related bone loss. J. Clin. Invest. 71: 1316–1321

    PubMed  CAS  Google Scholar 

  7. COUTRIS G., CAYLA Y., RONDIER J., TALBOT J. N., BONVARLET J. P., MILHAUD G. (1975). Analyse des perturbations des voies principales du métabolisme calcique dans la maladie de Paget. Rev. Rhum. 42: 759–767

    PubMed  CAS  Google Scholar 

  8. PRICE P. A., WILLIAMSON M. K. (1981) Effects of Warfarin on Bone. J. Biol. Chem. 256: 12754–12759

    PubMed  CAS  Google Scholar 

  9. BROWN J. P., DELMAS P. D., MALAVAL L., EDOUARD C., CHAPUY M. C., MEUNIER P. J., (1984). Serum Bone Gla-protein: a specific marker for bone formation in post menopausal osteoporosis. Lancet i 1091–1093

    Article  Google Scholar 

  10. POSEN S., GRUNSTEIN H. S. (1982) Turnover rates of skeletal alkaline phosphatase in humans. Clin. Chem. 28: 153–154

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Delmas, P.D., Demiaux, B., Malaval, L. et al. Serum bone GLA-protein is not a sensitive marker of bone turnover in Paget's disease of bone. Calcif Tissue Int 38, 60–61 (1986). https://doi.org/10.1007/BF02556596

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02556596

Key words

Navigation